Why is accessibility such a crucial consideration of open access publishing, and how can we ensure content is sufficiently accessible?
How have policies and mandates helped shape open access publishing, and what barriers exist that slow their implementation?
What are the benefits of open access publishing, and how can we improve equity in academic and medical communications?
Featuring new FDA guidance on diversity and inclusion in clinical trials, further calls for COVID-19 vaccine clinical trial transparency, how the UN is promoting open science, discussions on the evolving ecosystem of scientific publishing and two recent analyses of predatory journal watch lists.
Featuring the upcoming EMWA Virtual Conference, Open Pharma’s new open access advocacy resource, a joint appeal for open science, reflections on equitable scholarly communications, an example of a journal switching from hybrid to full open access and ideas on how to improve discoverability.
To celebrate Open Access Week 2020, Open Pharma teamed up with NetworkPharma and MedComms Networking to host an expert panel discussion on multi-stakeholder perspectives on open access publishing of pharma-sponsored research.
Featuring a round-up of Open Access Week events, highlights from our expert panel discussion with NetworkPharma, an announcement from Galápagos, an open access explainer video, the community’s input on equitable open access, a roadmap to equity in medical communications, and a new open access agreement from Nature.
As the UK and much of Europe face a second wave of COVID-19 and local lockdowns, we at Open Pharma continue to hope that all our readers are staying safe and well. We also know that the deluge of information on the COVID-19 outbreak can be incredibly taxing on our mental health so, throughout this period, we have been including links to several well-being resources at the bottom of each weekly digest and will continue to do so. We at Open Pharma would again like to encourage all our readers to look after themselves and their community, to wear a mask and to continue to follow advice from their country’s government and health organizations.
Featuring the latest signatory of Plan S, a think piece outlining the future of scholarly communications as the industry moves towards an open publishing model, the results from a survey on the economic impact of COVID-19 on professional societies, a new policy on price transparency from Gates Open Research and an analysis of figshare metadata on the usage of open research data.
Featuring the advent of ‘little’ subscription deals for libraries, a reminder of the upcoming Open Access Week panel discussion, a new upload to our figshare, a new trans-inclusive policy from F1000Research and Wellcome Open Research, further commitments to scientific integrity from vaccine developers, and the best and worst institutions in the USA for clinical trial transparency.